<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="retraction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2023.1292298</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: Magnetic resonance imaging and <sup>18</sup>F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Editorial Office</collab>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/228891/overview"/>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="edited-by"><p>Approved by: Giorgio Treglia, Ente Ospedaliero Cantonale (EOC), Switzerland</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Frontiers Editorial Office <email>research.integrity&#x00040;frontiersin.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1292298</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>09</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 Frontiers Editorial Office.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Frontiers Editorial Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Front. Med." journal-id-type="nlm-ta" vol="9" page="1024008" xlink:href="10.3389/fmed.2022.1024008" ext-link-type="doi">A Retraction of the Case Report Article <article-title>Magnetic resonance imaging and <sup>18</sup>F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: a case report</article-title> by Zeng, D.-B., Chang, C., Liu, X.-S., Gao, Y., Wang, Y.-L., and Pei, Z.-J. (2022). <italic>Front. Med</italic>. 9:1024008. doi: <object-id>10.3389/fmed.2022.1024008</object-id></related-article>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
<word-count count="353"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nuclear Medicine</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The journal retracts the 2022 article cited above.</p>
<p>Following concerns regarding the originality of the discussion in the article, an investigation was conducted in accordance with Frontiers&#x00027; policies. It was found that the complaint was valid and that the article should be retracted, because of an unacceptable high level of similarity to the discussion section of a different case study (article published by Yang et al., 2022: <italic>Chin J Nucl Med Mol Imaging</italic>, 2022, 42(3):174&#x02013;176. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3760/cma.j.cn321828-20220206-00031">10.3760/cma.j.cn321828-20220206-00031</ext-link>).</p>
<p>This retraction was approved by the Chief Editors of Frontiers in Medicine and the Chief Executive Editor of Frontiers. The authors agree to this retraction.</p>
</body>
</article>